Literature DB >> 12230005

Estimating the variance of disease-prevalence estimates from population-based registries.

Limin X Clegg1, Mitchell H Gail, Eric J Feuer.   

Abstract

We propose a new Poisson method to estimate the variance for prevalence estimates obtained by the counting method described by Gail et al. (1999, Biometrics 55, 1137-1144) and to construct a confidence interval for the prevalence. We evaluate both the Poisson procedure and the procedure based on the bootstrap proposed by Gail et al. in simulated samples generated by resampling real data. These studies show that both variance estimators usually perform well and yield coverages of confidence intervals at nominal levels. When the number of disease survivors is very small, however, confidence intervals based on the Poisson method have supranominal coverage, whereas those based on the procedure of Gail et al. tend to have below-nominal coverage. For these reasons, we recommend the Poisson method, which also reduces the computational burden considerably.

Mesh:

Year:  2002        PMID: 12230005     DOI: 10.1111/j.0006-341x.2002.00684.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  6 in total

1.  Improved population-based probability of developing cancer when direct estimates of the cancer-free population are available.

Authors:  Arianna Simonetti; Angela Mariotto; Martin Krapcho; Eric J Feuer
Journal:  Lifetime Data Anal       Date:  2012-03-20       Impact factor: 1.588

2.  Getting cancer prevalence right: using state cancer registry data to estimate cancer survivors.

Authors:  William R Carpenter; Wei-Shi Yeh; Sara E Wobker; Paul A Godley
Journal:  Cancer Causes Control       Date:  2011-03-01       Impact factor: 2.506

3.  Cancer survivors: a booming population.

Authors:  Carla Parry; Erin E Kent; Angela B Mariotto; Catherine M Alfano; Julia H Rowland
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-10       Impact factor: 4.254

4.  Increased risk of second primary malignancy in pediatric and young adult patients treated with radioactive iodine for differentiated thyroid cancer.

Authors:  Jennifer L Marti; Kunal S Jain; Luc G T Morris
Journal:  Thyroid       Date:  2015-05-06       Impact factor: 6.568

5.  Comparing trends in esophageal adenocarcinoma incidence and lifestyle factors between the United States, Spain, and the Netherlands.

Authors:  S Kroep; I Lansdorp-Vogelaar; J H Rubenstein; V E P P Lemmens; E B van Heijningen; N Aragonés; M van Ballegooijen; J M Inadomi
Journal:  Am J Gastroenterol       Date:  2013-12-17       Impact factor: 10.864

6.  The increasing incidence of thyroid cancer: the influence of access to care.

Authors:  Luc G T Morris; Andrew G Sikora; Tor D Tosteson; Louise Davies
Journal:  Thyroid       Date:  2013-04-18       Impact factor: 6.568

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.